Financial reports

rns
clockJun 26,2026

Full Year Results 2025

The Company aims to pursue investment opportunities that are positioned at pivotal moments in their development, where successful execution may lead to a substantial revaluation and accelerated growth.
Read the Article
rns
clockSep 26,2025

Interim Results 2025

  Igraine Plc – Interim Results for the Half-Year to 30 June 2025 PR Newswire     THE DIRECTORS OF IGRAINE PLC CONSIDER THIS ANNOUNCEMENT TO CONTAIN INSIDE INFORMATION FOR THE PURPOSES OF ARTICLE 7 OF REGULATION (EU) NO. 594/2014 OF THE EUROPEAN PARLIAMENT AND THE COUNCIL OF 16 APRIL…
Read the Article
2151904329
clockJun 01,2025

Full Year Results 2024

The Company aims to pursue investment opportunities that are positioned at pivotal moments in their development, where successful execution may lead to a substantial revaluation and accelerated growth.
Read the Article
rns
clockSep 24,2024

Interim Results 2024

Igraine Plc – Interim Results to 30 June 2024 and Investee: Oscillate Plc posting of circular to approve acquisition PR Newswire THE DIRECTORS OF IGRAINE PLC CONSIDER THIS ANNOUNCEMENT TO CONTAIN INSIDE INFORMATION FOR THE PURPOSES OF ARTICLE 7 OF REGULATION (EU) NO. 594/2014 OF THE EUROPEAN PARLIAMENT AND THE…
Read the Article
2151904329
clockJun 01,2024

Full Year Results 2023

During the financial year ended 31 December 2023, Igraine Plc faced a challenging market environment, reflecting broader economic uncertainties and volatility in the small cap space within the UK.
Read the Article
rns
clockSep 29,2023

Interim Results 2023

Igraine Plc – Interim Results for the Half-Year to 30 June 2023 PR Newswire The information contained within this announcement is deemed by the Company to constitute inside information as stipulated under the Market Abuse Regulation (EU) No. 596/2014 as amended by The Market Abuse (Amendment) (EU Exit) Regulations 2019.…
Read the Article
rns
clockSep 23,2022

Interim Results 2022

Igraine Plc – Interim Results for the Half-Year to 30 June 2022 PR Newswire THE DIRECTORS OF IGRAINE PLC CONSIDER THIS ANNOUNCEMENT TO CONTAIN INSIDE INFORMATION FOR THE PURPOSES OF ARTICLE 7 OF REGULATION (EU) NO. 594/2014 OF THE EUROPEAN PARLIAMENT AND THE COUNCIL OF 16 APRIL 2014 ON MARKET…
Read the Article
rns
clockDec 22,2021

Igraine Plc – Interim Results to 30 June 2021

Igraine Plc – Interim Results to 30 June 2021 PR Newswire THE DIRECTORS OF IGRAINE PLC CONSIDER THIS ANNOUNCEMENT TO CONTAIN INSIDE INFORMATION FOR THE PURPOSES OF ARTICLE 7 OF REGULATION (EU) NO. 594/2014 OF THE EUROPEAN PARLIAMENT AND THE COUNCIL OF 16 APRIL 2014 ON MARKET ABUSE AS IT…
Read the Article
2151904329
clockJun 01,2021

Final Report and Accounts – 2021

Igraine, is an investment issuer listed on the Access Segment of the AQSE Growth Market Exchange. The Company maintains an investment strategy focused on the evaluation of innovative technologies and commercially attractive discoveries in the health, medtech, biotech and life science sectors worldwide.
Read the Article

Create your account